Vacina/Vacinação - Calendários vacinais da Europa
Esta página já teve 88.934.897 acessos - desde 16 maio de 2003. Média de 26.983 acessos diários
home | entre em contato
 

Vacina/Vacinação

Calendários vacinais da Europa

13/06/2003

 

Áustria
Bélgica
Dinamarca
Finlândia
França
Alemanha
Grécia
Islândia
Irlanda
nascimento
      BCG BCG (1) HB1(23)     BCG(6)
1 mês
          HB2(23)      
2 meses
DTaP - IPV - Hib - HB1 DT(a or w)P1 + Hib1 + IPV1     DTwP - IPV1 - Hib1 + HB1 DT(a or w)P1 + Hib1 + IPV1 + HB1(5) DT(a or w)P1(28) + OPV1 + Hib1 + HB1: 2/3 m(29)   DTaP - IPV - Hib1
3 meses
DTaP - IPV - Hib - HB2 DT(a or w)P2 + Hib2 + IPV2 + HB1 DTaP - IPV1 + Hib1 DTwP1 DTwP - IPV2 - Hib2 + HB2 DT(a or w)P2 or DT(a or w)P2 - Hib2 - IPV2(24)   DTwP1 + Hib1  
4 meses
DTaP - IPV - Hib - HB3 DT(a or w)P3 + Hib3 + IPV3 + HB2   DTwP2 + Hib1 DTwP - IPV3 - Hib3 DT(a or w)P3 + Hib2 + IPV2 + HB2(5) or DT(a or w)P3 - Hib3 - IPV3(24) DT(a or w)P2 + OPV2 + Hib2 + HB2: 4/5 m DTwP2 + Hib2 DTaP - IPV - Hib2
5 meses
    DTaP - IPV2 + Hib2 DTwP3          
6 meses
      IPV1 + Hib2   HB3(23) DT(a or w)P3 + OPV3 + Hib3: 6/7 m DTwP3 + Hib3 + IPV1 DTaP - IPV - Hib3
8 meses
        HB3   HB3: 8/9 m    
7 meses               Polio  
9 meses
                 
10 meses
                 
11 meses
          DT(a or w)P4(16) + Hib3 + IPV3 + HB3 or DT(a or w)P4(16) - Hib4 - IPV4(24) + MMR1: 11/14m      
12 meses
    DTaP - IPV3 + Hib3 IPV2 MMR1 + HB3(22)   MMR1: 12/15 m   MMR1: 12/15 m
13 meses
DTaP - IPV - Hib4 + HB4: 13/18m DT(a or w)P4 + Hib4 + IPV4 + HB3: 13/18m              
14 meses MMR1 MMR1: 14/18m   MMR1 + Hib3: 14/18m       DTwP4 + Hib4 + IPV  
15 meses     MMR1            
16 meses         DT(a or w) P - IPV4 - Hib4 + HB3(22): 16/18m        
18 meses             DT(a or w)P4 + OPV4 + Hib4 MMR1  
20 meses       DTwP4 + IPV3: 20/24m          
2 anos
    OPV1            
3 anos     OPV2   MMR2: 3/6y     IPV  
4 anos
    OPV3     Td5(25) + MMR2: 4/5y DT(a or w)P5 or DT5 + OPV5: 4/6 y
MMR2: 4/6 y
  DTaP - IPV4: 4/6y
MMR2: 4/5y
5 anos
  DT5(+/- aP5) + IPV5 + MMR1 (5): 5/6y dT4       BCG: 5/6 y DT5  
6 anos
dT-IPV5
MMR2
    IPV4 + MMR2 DT5 + IPV5 + BCG(4)(5)(19) + MMR1(5) or 2        
7 anos
                 
9 anos
              IPV, MMR2 BCG(4) or (5): 10/14y
10 anos
          IPV4 or IPV5(24)(25); aP5: 10/17y
Td6(25) + HB(5) or (21) + MMR(5) or (21): 10/17y
     
11 anos
  HB(5)(10): 11/12y
MMR2: 11/12y
  IPV5
Td + MMR(5?) + IPV6: 11/13y
BCG(4) + DT6 -aP5 - IPV6 + HB(5): 11/13y
MMR1(5): 11/13y
       
12 anos
    MMR2         R(susceptible girls)  
13 anos
HB(5)
MMR2(5)
               
14 anos
  Td6: 14/16y         Td: 14/16 y IPV  
15 anos
TdIPV6: 14-15y           OPV6: 15/18y (30)   Td5: school leaving (#15/18 y )
16 anos
        BCG(4) + DT7 - IPV7 + R(2)(5): 16/18y        
17 anos
                 
18 anos
    R(2): from 18y            
adultos
dT - IPV: every 10y d; T: every 10y d; T: every 10y or if wound OPV: 3doses IPV: 1 after 4y and a 5th after 5y T; IPV: every 10y HB: every 5y for at risk d ;T: every 10y d; T: every 10y   T: 0 after 5 doses except if wound

Itália
Luxemburgo
Holanda
Noruega
Portugal
Espanha
Suécia
Suíça
Reino Unido
nascimento
        BCG : 0/1 m + HB1 HB1(6)     BCG (1)
1 mês
  HB1 BCG(1)              
2 meses
DTaP1 + IPV1 + Hib1 + HB1 DTaP1 - Hib1 - IPV1: 2/3m DTwP1 - IPV1 + Hib1   DTwP1 + OPV1 + Hib1 + HB2 DTwP1(6) or DTaP1(6) + OPV1 + Hib1 + HB2(6) + conjMenC(6): 2/3 m   DT(a or w)P1 + Hib1 + IPV1 DwPT1 + OPV1 + Hib1 + conjMenC1
3 meses
  DTaP2 - Hib2 - IPV2 + HB2: 3/5 m DTwP2 - IPV2 + Hib2 DTaP1 + IPV1 + Hib1     DTaP1 + IPV1 + Hib1   DwPT2 + OPV2 + Hib2 + conjMenC2
4 meses
DTaP2 + IPV2 + Hib2 + HB2 DTaP3 - Hib3 - IPV3: 4/6 m DTwP3 - IPV3 + Hib3   DTwP2 + OPV2 + Hib2 DTwP2(6) or DTaP2(6) + OPV2 + Hib2 + conjMenC(6): 4/5 m   DT(a or w)P2 + Hib2 + IPV2 DwPT3 + OPV3 + Hib3 + conjMenC3
5 meses
      DTaP2 + IPV2 + Hib2     DTaP2 + IPV2 + Hib2   conjMenC1 e 2(5): 5/12 m
6 meses
        DTwP3 + OPV3 + Hib3 + HB3 HB3(6) + DTwP3(6) or DTaP3(6) + OPV3 + Hib3 + conjMenC(6): 6/7m   DT(a or w)P3 + Hib3 + IPV3  
8 meses
                 
9 meses
                 
10 meses
Hib 3 e DTaP3 + OPV3 + HB3: 10/11m                
11 meses
MMR1: 11/14m DTaP4 - Hib4 - IPV4 + HB3: 11/12 m DTwP4 - IPV4 + Hib4 DTaP3 + IPV3 + Hib3: 11/12 m          
12 meses
            DTaP3 + IPV3 + Hib3   MMR1: 12/15m ConjMenC1(5): 1/5 y
13 meses
                 
14 meses     MMR1            
15 meses   MMR1: 15/18 m   MMR1 MMR1 MMR1: 15/18m (11)   DTaP4 + OPV1 or IPV4 + Hib4 + MMR 1: 15/23m  
16 meses                  
18 meses         DTwP4: 18/24 m + Hib4 DTwP4 or DT4(6) or DTaP(6) + OPV4 + Hib4 MMR1    
20 meses                  
2 anos
OPV4                
3 anos                 MMR2 DT4 + OPV4: 3/5 y
4 anos
DTaP4: 4/5y
MMR2: 4/5y or 10/11y
  dTIPV5     MMR2(6): 4-6 years   DTaP5 + OPV2 or IPV5 + MMR2: 4/7y  
5 anos
  Td5 + IPV5 + MMR2: 5/7 y     DTwP5 + OPV4 + BCG(4) + MMR2: 5/6y   IPV4: 5/6 y    
6 anos
          DT5(6) or DTaP(6) + OPV5      
7 anos
      IPV4          
9 anos
    dTIPV6 + MMR2            
10 anos
HB(5): 10/11 y
Td5:10/11 or 13/14 y
          DT4 or DTaP4(20)   BCG(4): 10/14 y
11 anos
      DT4 : 11/12y T6 + HB1,2,3(10)
BCG(4): 11/13 y
MMR2(5)(6) + HB1,2,3(5): 11/13y   dT6 + HB(10) + MMR2(22): 11/15y  
12 anos
  HB(5)(10) + Td6 + IPV6: 12/15 y   MMR2 : 12/13y     MMR2    
13 anos
      IPV5 + BCG: 13/14y         Td5 + OPV5: 13/18 y
14 anos
          Td6 + OPV(6)      
15 anos
                MenC (or ConjMenC):1st year at university
16 anos
                 
17 anos
                 
18 anos
                 
adultos
d; T: every 10y     d; T: every 10y d, T: every 10y d; T: every 10y d:1after10y and a 5th after 30y; IPV: 1 after 5y d; T : every 10y T: 0 after 5 doses except if wound

1 month means at 30 days of life ( and not during the first month)
2/3 months means between the 60th and the 90th day of life

A " + " between vaccines means association whereas a "- " stands for combination

w: weeks
m: months
y: years
/: between
-: combination
(1): at risks infants only
(2): girls only
(3): boys only
(4): if Mantoux test is negative
(5): if not vaccinated before
(6): in some districts only
(7): booster if vaccinated before or primoimmunisation
(8): according to physician's decision
(9): the need for a booster will be rediscussed in the light of further data
(10): doses at 0, 1, 6 months
(11): in case of special risk only : 1 dose at 9 months or earlier
(12): all children vaccinated before or not
(13): if travel in an endemic country
(14): as soon as vaccine available
(15): if didn't receive a 2nd dose
(16): preferably aP
(17): or primoimmunisation if not done before
(18): vaccination can begin latter : should be done between 3 months and 13 years. Schedule can be 2+1 or 3+1
(19): at this age or before
(20): catch up for aP
(21): To finish an incomplete schedule
(22): If not given before
(23): If the mother is HBsAg positive or not tested for HBsAg
(24): If pentavalent vaccine is/was used
(25): If the last vaccination was less than 12 month ago, the vaccination can be omittted
(26): aPer in the flemish community
(27): aPer only available throught national tender
(28): in practice acP is more used than wcP
(29): Until thiomersal free products are available, it is recommended to wait until the 6th month of age to start HB vaccination (except for new borns from HBsAg positive mothers)
(30): Consideration instead of recommendation

Sources:

Austria: Bundesministerium für Arbeit, gesundheit und Soziales
Belgium: Direction générale de la santé
Denmark: EPI-News-Statens Serum Institut
France: Conseil supérieur d'hygiène publique de France
Direction générale de la santé
Germany: Robert-Koch-Institut (STIKO)
Ireland: Immunisation guidelines for Ireland
National immunisation committee
Royal college of physicians of Ireland
Italy: Ministero della Sanità
Luxemburg: Secretariat general de la direction de la santé
Netherlands: Staatstoezicht op de volksgezondheid
Norway: Meldingsystem for Smittsomme Sykdommer - Statens Institutt for folkehelse
Sweden: Socialstyrelsen
SOSFS: Smittskyddssektionen Folkhälsoenheten (Swedish National Board of health - Section for Infectious Diseases - Unit of public health)
Switzerland: Office fédéral de la santé publique et Commission suisse pour les vaccinations


IMPORTANTE

  •  Procure o seu médico para diagnosticar doenças, indicar tratamentos e receitar remédios. 
  • As informações disponíveis no site da Dra. Shirley de Campos possuem apenas caráter educativo.
Publicado por: Dra. Shirley de Campos
versão para impressão

Desenvolvido por: Idelco Ltda.
© Copyright 2003 Dra. Shirley de Campos